SARS-CoV-2 Viral Load in the Pulmonary Compartment of Critically Ill COVID-19 Patients Correlates with Viral Serum Load and Fatal Outcomes.

COVID-19 SARS-CoV-2 bronchoalveolar lavage critical care qPCR

Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
14 06 2022
Historique:
received: 15 05 2022
accepted: 10 06 2022
entrez: 24 6 2022
pubmed: 25 6 2022
medline: 28 6 2022
Statut: epublish

Résumé

While SARS-CoV-2 detection in sputum and swabs from the upper respiratory tract has been used as a diagnostic tool, virus quantification showed poor correlation to disease outcome and thus, poor prognostic value. Although the pulmonary compartment represents a relevant site for viral load analysis, limited data exploring the lower respiratory tract is available, and its association to clinical outcomes is relatively unknown. Using bronchoalveolar lavage (BAL) and serum samples, we quantified SARS-CoV-2 copy numbers in the pulmonary and systemic compartments of critically ill patients admitted to the intensive care unit of a COVID-19 referral hospital in Croatia during the second and third pandemic waves. Clinical data, including 30-day survival after ICU admission, were included. We found that elevated SARS-CoV-2 copy numbers in both BAL and serum samples were associated with fatal outcomes. Remarkably, the highest and earliest viral loads after initiation of mechanical ventilation support were increased in the non-survival group. Our results imply that viral loads in the lungs contribute to COVID-19 disease severity, while blood titers correlate with lung virus titers, albeit at a lower level. Moreover, they suggest that BAL SARS-CoV-2 copy number quantification at ICU admission may provide a predictive parameter of clinical COVID-19 outcomes.

Identifiants

pubmed: 35746764
pii: v14061292
doi: 10.3390/v14061292
pmc: PMC9228931
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Clin Infect Dis. 2021 Nov 2;73(9):e2995-e3001
pubmed: 32856036
Lancet Respir Med. 2021 Jun;9(6):665-672
pubmed: 34000237
Nat Med. 2020 Jun;26(6):861-868
pubmed: 32327757
Virol J. 2021 Feb 10;18(1):33
pubmed: 33568204
N Engl J Med. 2020 Oct 29;383(18):1757-1766
pubmed: 32329974
N Engl J Med. 2020 Dec 17;383(25):2451-2460
pubmed: 32412710
Clin Infect Dis. 2021 May 4;72(9):e291-e295
pubmed: 32965474
Intervirology. 2020 Dec 9;:1-12
pubmed: 33296901
Am J Pathol. 2020 Sep;190(9):1881-1887
pubmed: 32628931
Clin Infect Dis. 2021 Nov 2;73(9):e2890-e2897
pubmed: 32803231
Crit Care. 2020 Oct 16;24(1):610
pubmed: 33066801
Am J Respir Crit Care Med. 2021 Jan 1;203(1):54-66
pubmed: 33119402
Am J Respir Crit Care Med. 2021 Jan 1;203(1):127-129
pubmed: 33125256
Clin Infect Dis. 2021 Aug 2;73(3):e799-e802
pubmed: 32888003
Clin Infect Dis. 2020 Nov 5;71(8):1937-1942
pubmed: 32301997
Pathogens. 2021 Jun 20;10(6):
pubmed: 34203060
Nat Commun. 2021 Jun 7;12(1):3406
pubmed: 34099652
Nat Med. 2021 Jan;27(1):28-33
pubmed: 33442016
Front Med (Lausanne). 2021 Jan 14;7:560685
pubmed: 33521004
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
Biochem Med (Zagreb). 2021 Jun 15;31(2):020706
pubmed: 33927556
Am J Trop Med Hyg. 2020 Dec 23;104(2):540-545
pubmed: 33357280
Nat Commun. 2020 Oct 30;11(1):5493
pubmed: 33127906
Osong Public Health Res Perspect. 2020 Jun;11(3):112-117
pubmed: 32528816
Nature. 2020 Aug;584(7821):430-436
pubmed: 32640463
J Med Virol. 2021 May;93(5):3165-3175
pubmed: 33590923
BMJ. 2020 May 22;369:m1966
pubmed: 32444366
J Med Virol. 2022 Jan;94(1):147-153
pubmed: 34411312
Ann Intensive Care. 2020 Dec 10;10(1):167
pubmed: 33301059
JAMA. 2012 Jun 20;307(23):2526-33
pubmed: 22797452
Crit Care Med. 2020 Sep;48(9):e799-e804
pubmed: 32452888
Clin Infect Dis. 2021 May 4;72(9):e446-e447
pubmed: 32770223
Sci Rep. 2021 Jun 23;11(1):13134
pubmed: 34162948
J Infect. 2021 Sep;83(3):381-412
pubmed: 34087349
Clin Infect Dis. 2022 May 3;74(9):1525-1533
pubmed: 34374761
JAMA. 2020 May 12;323(18):1843-1844
pubmed: 32159775
N Engl J Med. 2020 May 21;382(21):2012-2022
pubmed: 32227758
BMJ. 2020 Apr 21;369:m1443
pubmed: 32317267
JAMA. 2020 Jun 2;323(21):2195-2198
pubmed: 32329797
Infection. 2021 Feb;49(1):117-126
pubmed: 33231841
Nature. 2020 Mar;579(7798):265-269
pubmed: 32015508
Intensive Care Med. 2020 Nov;46(11):2026-2034
pubmed: 32886208
J Transl Med. 2021 Jan 7;19(1):30
pubmed: 33413461

Auteurs

Mario Ynga-Durand (M)

Helmholtz Center for Infection Research, Department of Viral Immunology, 38124 Braunschweig, Germany.

Henrike Maaß (H)

Helmholtz Center for Infection Research, Department of Viral Immunology, 38124 Braunschweig, Germany.

Marko Milošević (M)

Department of Anesthesiology, Reanimation, Intensive Care and Emergency Medicine, Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia.

Fran Krstanović (F)

Center for Proteomics, Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia.

Marina Pribanić Matešić (M)

Center for Proteomics, Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia.

Stipan Jonjić (S)

Center for Proteomics, Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia.

Alen Protić (A)

Department of Anesthesiology, Reanimation, Intensive Care and Emergency Medicine, Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia.

Ilija Brizić (I)

Center for Proteomics, Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia.

Alan Šustić (A)

Department of Anesthesiology, Reanimation, Intensive Care and Emergency Medicine, Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia.
Department of Clinical Medical Science II, Faculty of Health Studies, University of Rijeka, 51000 Rijeka, Croatia.

Luka Čičin-Šain (L)

Helmholtz Center for Infection Research, Department of Viral Immunology, 38124 Braunschweig, Germany.
German Centre for Infection Research (DZIF), Partner Site Hannover/Braunschweig, 38124 Braunschweig, Germany.
Centre for Individualised Infection Medicine (CiiM), A Joint Venture of Helmholtz Centre for Infection Research and Hannover Medical School, 30625 Hannover, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH